Aberrant Expression of RAD52, Its Prognostic Impact in Rectal Cancer and Association with Poor Survival of Patients
Vincent Ho(Camden and Campbelltown Hospitals), Cheok Soon Lee(Liverpool Hospital), Weng Ng(Sir Run Run Shaw Hospital), Vivienne Lea(Liverpool Hospital), Stephanie Lim(Camden and Campbelltown Hospitals), Tara L. Roberts(Camden and Campbelltown Hospitals), Liping Chung(Camden and Campbelltown Hospitals), Wei Chua(Liverpool Hospital), Mark Lee, Paul de Souza(St. George Hospital), Amandeep Singh(Camden and Campbelltown Hospitals), Askar Abubakar(Camden and Campbelltown Hospitals)
Cited by 19
Related Papers
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
|The Lancet Oncology|2015|1.4k
HIN-200 Proteins Regulate Caspase Activation in Response to Foreign Cytoplasmic DNA
|Science|2009|822
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial
|The Lancet Oncology|2023|663
AIM2 and NLRP3 inflammasomes activate both apoptotic and pyroptotic death pathways via ASC
|Cell Death and Differentiation|2013|507